home All News open_in_new Full Article

NetraMark Appoints Jan Sedway as Senior Vice President of Clinical Science to Accelerate Growth and Market Leadership

TORONTO, Aug. 12, 2025 (GLOBE NEWSWIRE) — NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt:PF0) a premier artificial intelligence (AI) company transforming clinical trials today announced the appointment of Jan Sedway, Ph.D., as Senior Vice President of Clinical Science. As NetraMark strategically expands its footprint in the pharmaceutical industry, this appointment […]


today 49 h. ago attach_file Politics

attach_file Politics
attach_file Other
attach_file Society
attach_file Other
attach_file Other
attach_file Other
attach_file Culture
attach_file Other
attach_file Economics


ID: 1864475502
Add Watch Country

arrow_drop_down